- Home
- Software Solutions
- Resources
- Corporate
A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adults With Myelofibrosis
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 54 | |
Additional information about NCT01369498.